Griffon Pharmaceuticals International SA
Biotechnology and Pharmaceuticals
Griffon Pharmaceuticals International SA è una AG svizzera con sede a Epalinges, VD. La sua attività registrata rientra in Ricerca e sviluppo nell'industria farmaceutica.
Dati arricchiti con IA· contrassegna i campi arricchiti con IA
AI Insight
Sintesi del registro generata dai fatti FUSC.
Organi2Relazioni attive2Relazioni cancellate0Pubblicazioni FUSC1Prima iscrizione25.01.2019Ultima attività30.01.2019
Informazioni del registro
Indirizzo c/o
- Swiss UID
- CHE-470.574.202
- Legal Name
- Griffon Pharmaceuticals International SA
- Legal Form
- Limited
- Incorporated
- 25 Jan 2019
- Share Capital
- 1'000 actions nominatives de CHF 100, avec restrictions quant à la transmissibilité selon statuts.
- Canton
- VD
- Status
- Active
- Country
- Switzerland
Scopo aziendale
Traduzione in corso…
Codici NOGA
(Classificazione settoriale)Ricerca e sviluppo nell'industria farmaceutica
NATTIVITÀ PROFESSIONALI, SCIENTIFICHE E TECNICHE72Ricerca scientifica e sviluppo721Ricerca e sviluppo sperimentale nel campo delle scienze naturali e dell’ingegneria7210Ricerca e sviluppo sperimentale nel campo delle scienze naturali e dell’ingegneria721001
Salute del settore
Indirizzo registrato
Route de la Corniche 3, c/o Biopôle SA, Bâtiment SE-A, 1066 Epalinges
1066, Epalinges, VD
Aziende a questo indirizzo
Arricchisci dalle integrazioni
Recuperate i dati dai vostri fornitori collegati e uniteli con il registro.
Polso del registro
Il polso del registro è una funzione Pro
Amministratori & organi attuali
Dal web
Fonti (7)
Full List of Biotech Companies in Switzerland (2026)
pharmchoices.com
Griffon Pharmaceuticals International • Biopôle • Switzerland
biopole.ch
Griffon Pharmaceuticals International SA, Epalinges | OnlineInfo.ch Firmeninformation
onlineinfo.ch
Marc Cluzel: Postes, Relations & Réseau - Zonebourse
zonebourse.com
Pegylated bioactive peptides and uses thereof (US Patent 10918730)
exa.ai
Attending companies 2025 - Swiss Biotech Day
swissbiotechday.ch
NOTICE: CORRECTION TO NOTICE OF INTENT ISSUED JAN. 25, 2021 - VA Offer of Exclusive Patent License to Griffon Pharmaceuticals Inc. BY THE: Department of Veterans Affairs, Office of Research and Development (VA) ON: March 25, 2021 SUMMARY: As stated in the original notice of January 25, 2021, the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to Griffon Pharmaceuticals, an exclusive license to U.S. Patent Application No. 16/611,147 and PCT/US2018/031261, associated with VA Invention Disclosure number 2016-145 titled, “Methods and Composition for Treating Liver Disease”. However, Griffon Pharmaceuticals’ corporate entity and address for this license agreement have changed to the following: Griffon Pharmaceuticals International SA, Route de la Corniche 3, Bâtiment SE-A, 1066 Épalinges, Switzerland. TECH NAME: “Methods and Composition for Treating Liver Disease” ACTION: CORRECTION TO NOTICE OF INTENT DATES: Comments must be received on or before April 14, 2021. ADDRESS: Send comments to Mr. Stefan Susta, Technology Transfer Specialist, Office of Research and Development (14RDTT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (937) 409-7993 (this is not a toll-free number), Email: stefan.susta@va.gov FOR FURTHER INFORMATION CONTACT: Send comments to Mr. Stefan Susta, Technology Transfer Specialist, Office of Research and Development (14RDTT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (937) 409-7993 (this is not a toll-free number), Email: stefan.susta@va.gov
federallabs.org